Skip to main content
Inc. 5000 badge graphic. Facility Logix makes 2023 Inc. 5000

Inc. 5000 Spotlights FLGX Growth.

2023 marked the second consecutive year Facility Logix was named to the Inc. 5000 list of the nation's fastest-growing privately-held companies. Year after year, FLGX is growing by serving clients with the kind of excellence they can rely on for project after project. In 2022–2023, 59% of our business came from repeat cients. As the science and innovation sector continues to grow, our clients are flourishing, and we are proud to grow by supporting them in their important work.

Inc. 5000 badge graphic. Facility Logix makes 2023 Inc. 5000

Inc. 5000 Spotlights FLGX Growth.

2023 marked the second consecutive year Facility Logix was named to the Inc. 5000 list of the nation's fastest-growing privately-held companies. Year after year, FLGX is growing by serving clients with the kind of excellence they can rely on for project after project. In 2022–2023, 59% of our business came from repeat cients. As the science and innovation sector continues to grow, our clients are flourishing, and we are proud to grow by supporting them in their important work.

Growing Lab/Manufacturing Company

Let Facility Logix work as an extension of your organization to provide an end-to-end spectrum of services from Site Selection and Feasibility Analysis through Design and Construction and well beyond. Whether as Owner’s Representative or in another capacity, at each stage we help to realize your project’s full potential, allowing your organization to focus on your critical mission.

Developer/Building or Site Owner

An independent evaluation by Facility Logix, informed by integrated cross-disciplinary expertise and experience, provides an accurate Facility Assessment of the condition, risk, and suitability for particular use(s) of a given property. We can also open more robust opportunities and possibilities in any Facility Divestment and Repositioning.

Research/Higher Education Institution and/or Economic Development Organization

Bring greater prosperity to your region with an independent, third-party perspective. A Facility Logix Market Analysis provides a comprehensive picture of your region’s strengths and challenges and includes SWOT analysis as well as actionable steps. We’ve helped 30+ communities across the nation imagine possibilities and realize them. Let us put your community “on the map,” too.

Case Studies

Maxcyte® project photo

Maxcyte®

tape icon
Project Size
Aggregate 53,000 SF (Phases 1-3)
calendar icon
Schedule
Aug 2022

On a solid foundation of more than 20 years’ experience perfecting the art of cell engineering, MaxCyte is opening exciting new possibilities in cell-based therapies with ExPERTTM instruments, bringing together best-in-class electroporation technology with seamless scalability. The challenge: Scattered operations and a lack of facility cohesion prevented the company from...
Read More about Maxcyte®

Innovation Ecosystem Market Assessment for the Delaware Prosperity Partnership project photo

Innovation Ecosystem Market Assessment for the Delaware Prosperity Partnership

tape icon
Project Size
Comparative analysis across 5 key industries
calendar icon
Schedule
Jan 2018

In 2018, Facility Logix conducted a thorough market analysis of key industries in Delaware, including chemistry, advanced materials, biotech, medical device, and healthcare. Comparing competitiveness with neighboring states, we developed a strategic action plan to enhance Delaware's innovation ecosystem. Presenting directly to the governor, our plan outlined targeted initiatives for...
Read More about Innovation Ecosystem Market Assessment for the Delaware Prosperity Partnership

CvilleBioHub Feasibility Study project photo

CvilleBioHub Feasibility Study

tape icon
Project Size
Survey and Comprehensive 4-Part Support Program
calendar icon
Schedule
Mar 2020 -
Jul 2020

Our engagement in the CvilleBioHub project involved conducting a comprehensive survey to assess the space requirements for a multi-tenant life science lab facility. Based on this survey, we developed a program, capital budget, operating budget, and operational framework to support the development of the proposed facility. To ensure accuracy and...
Read More about CvilleBioHub Feasibility Study

1812 Ashland Accelerator Feasibility Study project photo

1812 Ashland Accelerator Feasibility Study

tape icon
Project Size
30,000 SF
calendar icon
Schedule
Jun 2016

In 2015, Facility Logix conducted a feasibility study for Johns Hopkins University’s Technology Ventures and FastForward, assessing the supply and demand for early-stage lab space in the Baltimore area and proposing a lab space program that addressed lab areas, size, and functions to be performed within the space, along...
Read More about 1812 Ashland Accelerator Feasibility Study

1812 Ashland Accelerator project photo

1812 Ashland Accelerator

tape icon
Project Size
30,000 SF
calendar icon
Schedule
Jun 2016

The challenge: Johns Hopkins University’s Technology Ventures and the University’s FastForward team sought to maximize the impact of University research by facilitating the transfer of research discovery. A feasibility study conducted by Facility Logix identified demand for early-stage lab space in the Baltimore area. FLGX&rsquo...
Read More about 1812 Ashland Accelerator

Vita Therapeutics project photo

Vita Therapeutics

tape icon
Project Size
11,000 SF
calendar icon
Schedule
Aug 2022

Founded by industry pioneers including Dr. Doug Ethell and Robert M. Laverty, Vita Therapeutics is a cell engineering company harnessing the power of genetics to develop cellular treatment for muscular dystrophy and solid tumors. The company uses induced pluripotent stem cell technology to engineer specific cell types to replace defective...
Read More about Vita Therapeutics

Vaccitech project photo

Vaccitech

tape icon
Project Size
16,000 SF
calendar icon
Schedule
Apr 2023

A spinout of Oxford University, Vaccitech discovers and develops immunotherapeutic products and vaccines for the treatment and prevention of infectious disease and cancer. In 2021, the company expanded with the acquisition of Avidia Technologies in Maryland. The challenge: With the acquisition and with six clinical candidates ready to advance to trials,...
Read More about Vaccitech

Sirnaomics project photo

Sirnaomics

tape icon
Project Size
45,000 SF
calendar icon
Schedule
Oct 2022

Sirnaomics is a clinical-stage RNA therapeutics biopharmaceutical company discovering and developing innovative drugs for treatments in cancer, fibrosis, medical aesthetics, and antivirals. The challenge: With 16 clinical trials currently underway, the company needed a new headquarters and lab that would accommodate the company’s unique operational needs for a higher-than-average...
Read More about Sirnaomics

On-Demand Pharmaceuticals project photo

On-Demand Pharmaceuticals

tape icon
Project Size
43,000 SF
calendar icon
Schedule
Nov 2021

On-Demand Pharmaceuticals (ODP) is developing a mobile, vending machine-like dispensary for front-line military, first responders, and other remote locations. ODP was founded by the founding director of the DARPA Biological Technologies Office, LTC (R) Geoff Ling, M.D., Ph.D. ODP occupies the former Supernus Pharmaceuticals Rockville facility. Facility Logix...
Read More about On-Demand Pharmaceuticals

Arcellx project photo

Arcellx

tape icon
Project Size
100,000 SF (Phased)
calendar icon
Schedule
Jun 2022

Arcellx was founded by serial entrepreneur and former Human Genome Sciences VP David Hilbert. Arcellx is developing CAR-T technologies to tackle multiple myeloma with a more efficacious and calcitrant treatment than is currently available. Early success has allowed Arcellx and Kite Pharma (Frederick, MD) to enter into a co-development partnership. ...
Read More about Arcellx

United Therapeutics project photo

United Therapeutics

tape icon
Project Size
28,000 SF
calendar icon
Schedule
Feb 2019

United Therapeutics (UT), a public biopharmaceutical company, focuses on the development and commercialization of products to address patients' unmet needs. UT created the Dinutuximab-Dedicated Oncology Medical and Analytical Laboratory (DDOMAL) to expand commercial manufacturing capacity for its pediatric high-risk neuroblastoma therapy. This project inspired a Montgomery County zoning amendment that...
Read More about United Therapeutics

Capital Digestive Care project photo

Capital Digestive Care

tape icon
Project Size
22,000 SF
calendar icon
Schedule
Jul 2022

Capital Digestive Care (CDC) is the largest gastroenterology group in the mid-Atlantic states with more than 200,000 patients each year. CDC needed a core laboratory with new technology evaluation capabilities. It recognized the need to relocate its Bowie, MD, operations, consolidating independent operations along the DC beltway to support lab tech...
Read More about Capital Digestive Care

Case Studies

Maxcyte®
Project Size: Aggregate 53,000 SF (Phases 1-3)
Schedule: Aug 2022

On a solid foundation of more than 20 years’ experience perfecting the art of cell engineering, MaxCyte is opening exciting new possibilities in cell-based therapies with ExPERTTM instruments, bringing together best-in-class electroporation technology with seamless scalability. The challenge: Scattered operations and a lack of facility cohesion prevented the company from...
Read More about Maxcyte®

Innovation Ecosystem Market Assessment for the Delaware Prosperity Partnership
Project Size: Comparative analysis across 5 key industries
Schedule: Jan 2018

In 2018, Facility Logix conducted a thorough market analysis of key industries in Delaware, including chemistry, advanced materials, biotech, medical device, and healthcare. Comparing competitiveness with neighboring states, we developed a strategic action plan to enhance Delaware's innovation ecosystem. Presenting directly to the governor, our plan outlined targeted initiatives for...
Read More about Innovation Ecosystem Market Assessment for the Delaware Prosperity Partnership

CvilleBioHub Feasibility Study
Project Size: Survey and Comprehensive 4-Part Support Program
Schedule: Mar 2020 - Jul 2020

Our engagement in the CvilleBioHub project involved conducting a comprehensive survey to assess the space requirements for a multi-tenant life science lab facility. Based on this survey, we developed a program, capital budget, operating budget, and operational framework to support the development of the proposed facility. To ensure accuracy and...
Read More about CvilleBioHub Feasibility Study

1812 Ashland Accelerator Feasibility Study
Project Size: 30,000 SF
Schedule: Jun 2016

In 2015, Facility Logix conducted a feasibility study for Johns Hopkins University’s Technology Ventures and FastForward, assessing the supply and demand for early-stage lab space in the Baltimore area and proposing a lab space program that addressed lab areas, size, and functions to be performed within the space, along...
Read More about 1812 Ashland Accelerator Feasibility Study

1812 Ashland Accelerator
Project Size: 30,000 SF
Schedule: Jun 2016

The challenge: Johns Hopkins University’s Technology Ventures and the University’s FastForward team sought to maximize the impact of University research by facilitating the transfer of research discovery. A feasibility study conducted by Facility Logix identified demand for early-stage lab space in the Baltimore area. FLGX&rsquo...
Read More about 1812 Ashland Accelerator

Vita Therapeutics
Project Size: 11,000 SF
Schedule: Aug 2022

Founded by industry pioneers including Dr. Doug Ethell and Robert M. Laverty, Vita Therapeutics is a cell engineering company harnessing the power of genetics to develop cellular treatment for muscular dystrophy and solid tumors. The company uses induced pluripotent stem cell technology to engineer specific cell types to replace defective...
Read More about Vita Therapeutics

Vaccitech
Project Size: 16,000 SF
Schedule: Apr 2023

A spinout of Oxford University, Vaccitech discovers and develops immunotherapeutic products and vaccines for the treatment and prevention of infectious disease and cancer. In 2021, the company expanded with the acquisition of Avidia Technologies in Maryland. The challenge: With the acquisition and with six clinical candidates ready to advance to trials,...
Read More about Vaccitech

Sirnaomics
Project Size: 45,000 SF
Schedule: Oct 2022

Sirnaomics is a clinical-stage RNA therapeutics biopharmaceutical company discovering and developing innovative drugs for treatments in cancer, fibrosis, medical aesthetics, and antivirals. The challenge: With 16 clinical trials currently underway, the company needed a new headquarters and lab that would accommodate the company’s unique operational needs for a higher-than-average...
Read More about Sirnaomics

On-Demand Pharmaceuticals
Project Size: 43,000 SF
Schedule: Nov 2021

On-Demand Pharmaceuticals (ODP) is developing a mobile, vending machine-like dispensary for front-line military, first responders, and other remote locations. ODP was founded by the founding director of the DARPA Biological Technologies Office, LTC (R) Geoff Ling, M.D., Ph.D. ODP occupies the former Supernus Pharmaceuticals Rockville facility. Facility Logix...
Read More about On-Demand Pharmaceuticals

Arcellx
Project Size: 100,000 SF (Phased)
Schedule: Jun 2022

Arcellx was founded by serial entrepreneur and former Human Genome Sciences VP David Hilbert. Arcellx is developing CAR-T technologies to tackle multiple myeloma with a more efficacious and calcitrant treatment than is currently available. Early success has allowed Arcellx and Kite Pharma (Frederick, MD) to enter into a co-development partnership. ...
Read More about Arcellx

United Therapeutics
Project Size: 28,000 SF
Schedule: Feb 2019

United Therapeutics (UT), a public biopharmaceutical company, focuses on the development and commercialization of products to address patients' unmet needs. UT created the Dinutuximab-Dedicated Oncology Medical and Analytical Laboratory (DDOMAL) to expand commercial manufacturing capacity for its pediatric high-risk neuroblastoma therapy. This project inspired a Montgomery County zoning amendment that...
Read More about United Therapeutics

Capital Digestive Care
Project Size: 22,000 SF
Schedule: Jul 2022

Capital Digestive Care (CDC) is the largest gastroenterology group in the mid-Atlantic states with more than 200,000 patients each year. CDC needed a core laboratory with new technology evaluation capabilities. It recognized the need to relocate its Bowie, MD, operations, consolidating independent operations along the DC beltway to support lab tech...
Read More about Capital Digestive Care

Greg Merrill

CEO and Co-Founder, Adaptive Phage Therapeutic

"It was such a successful program, working with Facility Logix. They really helped us manage costs, they kept the contractors on schedule and on time, they addressed issues, and they were a great facilitator of getting that program done quickly and on budget."

Watch Video

Kurt Foreman

President and CEO, Delaware Prosperity Partnership

"When you think about firms or you think about people you've worked with, sometimes words come to mind. And, for me, it starts with marketplace knowledge first and foremost. Customer focus, too. They honed in on us right away and I never feel like I'm the Friday-afternoon customer; I feel like we may be the only customer... I think they do a fabulous job."

Watch Video

Michael Dombeck

Chief Operating Officer, Arcellx, Inc

“Facility Logix assisted me in staying on top of everything as we transformed an old office into a new lab that would support R&D.”

Watch Video

Nick Fullenkamp

Vice President of Corporate Development, Vaccitech

"The Facility Logix team immediately brought expertise and credibility to our project. They also are experts in project management and that came across really clear right away... They do these builds all the time and they have a level of experience that most people in our industry do not."

Watch Video

Ron Holtz

CFO, MaxCyte®, Inc.

"The Facility Logix team really integrated with us as if they were employees of the company. They took it to heart. They treated it as if it was their own project. Being able to trust that it was managed by people who had the expertise to do it well was really important to having confidence that we were going to get to the right answer in the end."

Watch Video

Thomas Kaufman

Associate Vice President, United Therapeutics Corporation

"Facility Logix has a really deep understanding of the life science industry and they also understand the nuts and bolts of the design and construction process for complex facilities... It's really hard to find organizations that have both of those things, very few can marry both of those uniquely challenging worlds of design and construction and running a project, and the life science industry."

Watch Video

background image: asdf

Why Your Organization Should Choose Facility Logix

No other company in the industry combines the depth and diversity of Facility Logix experience and expertise—life sciences; design, program, and construction management; and economic development. Build a higher-functioning environment for innovation—faster and at lower costs—and reap the benefits of a facility that works on every level to support your mission and organizational goals.

 
asdf

Why Your Organization Should Choose Facility Logix

No other company in the industry combines the depth and diversity of Facility Logix experience and expertise—life sciences; design, program, and construction management; and economic development. Build a higher-functioning environment for innovation—faster and at lower costs—and reap the benefits of a facility that works on every level to support your mission and organizational goals.

 
background image: 3d rendering of buildin interior

Arcellx Expansion

When Arcellx needed more space for laboratory and research, Facility Logix provided end-to-end service, from helping the company understand the needed specifications through design, construction, and even relocation of staff.

Read more

Michael Dombeck Chief Operating Officer, Arcellx, Inc. photo

“Facility Logix assisted me in staying on top of everything as we transformed an old office into a new lab that would support R&D.”

- Michael Dombeck Chief Operating Officer, Arcellx, Inc.
3d rendering of buildin interior

Arcellx Expansion

When Arcellx needed more space for laboratory and research, Facility Logix provided end-to-end service, from helping the company understand the needed specifications through design, construction, and even relocation of staff.

Read more

Michael Dombeck Chief Operating Officer, Arcellx, Inc. photo

“Facility Logix assisted me in staying on top of everything as we transformed an old office into a new lab that would support R&D.”

- Michael Dombeck Chief Operating Officer, Arcellx, Inc.
background image: Patricia Larrabee in the field

Patricia Larrabee

Founder, President

Pat is the founder and president of Facility Logix. She has over 30 years of experience in the biotechnology industry, including several years as a bench researcher. For the past 20 years, Pat has applied her technical end-user knowledge to the facility-related needs of the industry.

photo
.(JavaScript must be enabled to view this email address)
Patricia Larrabee in the field

Patricia Larrabee

Founder, President

Pat is the founder and president of Facility Logix. She has over 30 years of experience in the biotechnology industry, including several years as a bench researcher. For the past 20 years, Pat has applied her technical end-user knowledge to the facility-related needs of the industry.

© Copyright 2023 Facility Logix. All rights reserved. | Website developed by Marketing Alliance Inc.
Terms & Conditions | Privacy Policy | Cookie Policy